UPDATE - UBS Initiates Coverage on Ubiquiti Networks (UBNT) with a Buy; Making Communications Ubiquitous
Tweet
Share
E-mailGet Alerts UBNT Hot Sheet
Price: $110.59 --0%
Rating Summary:
4 Buy, 12 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
4 Buy, 12 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UPDATE - UBS initiates coverage on Ubiquiti Networks (Nasdaq: UBNT) with a Buy rating. PT $25.
UBS analyst says, "As a provider of next generation communications systems, we foresee the company benefiting from the insatiable need for affordable broadband access and mobility. We foresee revenues growing from $198m in FY11 to $543m in FY14 (CAGR of 40%), with EPS increasing from $0.48 in FY11 to $1.48 in the same time period."
"We believe a combination of a large addressable market (UBS estimate $25-30b) and innovative business model that leverages the power of the UBNT community, mitigating the need for direct sales, marketing and support, should drive above industry-average sales growth and operating margin (UBSe 34.3% in FY12; 32.9% FY13). With its products optimized for price performance, the threat from low-cost competitors is minimized as well."
To See Ratings Summary & History on UBNT, Click Here
UBS analyst says, "As a provider of next generation communications systems, we foresee the company benefiting from the insatiable need for affordable broadband access and mobility. We foresee revenues growing from $198m in FY11 to $543m in FY14 (CAGR of 40%), with EPS increasing from $0.48 in FY11 to $1.48 in the same time period."
"We believe a combination of a large addressable market (UBS estimate $25-30b) and innovative business model that leverages the power of the UBNT community, mitigating the need for direct sales, marketing and support, should drive above industry-average sales growth and operating margin (UBSe 34.3% in FY12; 32.9% FY13). With its products optimized for price performance, the threat from low-cost competitors is minimized as well."
To See Ratings Summary & History on UBNT, Click Here
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DA Davidson Starts Everus (ECG) at Buy
- TD Cowen Assumes Atara Biotherapeutics (ATRA) at Buy
- Keefe, Bruyette & Woods Resumes Canadian Imperial Bank of Commerce (CM:CN) (CM) at Market Perform
Create E-mail Alert Related Categories
New CoverageRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
